V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20220877 | 20180794 | 1.65 | 91.4 | Neo-adjuvant (N) | 2018-02-04 | 2018-02-06 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100992867 |
| 20221057 | 20180795 | 1.73 | 63 | null | 2021-06-25 | 2021-09-14 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 100264853 |
| 20221103 | 20180796 | 1.75 | 92.6 | null | 2016-10-22 | 2016-10-30 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101482232 |
| 20221118 | 20180797 | 1.54 | 75.5 | null | 2017-01-17 | 2017-06-01 | CETUXIMAB | 02 | null | CETUXIMAB | 100595490 |
| 20221297 | 20180798 | 1.62 | 67 | Palliative (P) | 2018-04-16 | 2018-04-27 | Irinotecan + Modified De Gramont | 02 | N | IRINOTECAN + MDG | 100123939 |
| 20221413 | 20180799 | null | 67 | Palliative (P) | 2018-08-25 | 2018-09-24 | Irinotecan + Modified De Gramont | 02 | N | IRINOTECAN + MDG | 100575563 |
| 20221483 | 20180800 | 1.85 | 117 | null | 2021-12-29 | 2022-01-03 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100896888 |
| 20221872 | 20180801 | 1.57 | 81.9 | null | 2018-07-22 | 2018-07-22 | FLUOROURACIL + IRINOTECAN | 02 | null | IRINOTECAN + MDG | 101483998 |
| 20221911 | 20180802 | 1.76 | 77.9 | Palliative (P) | 2017-07-16 | 2017-07-19 | Irinotecan + Modified De Gramont | 02 | N | IRINOTECAN + MDG | 100526766 |
| 20221977 | 20180803 | 1.6 | 101.1 | null | 2016-10-21 | 2016-10-31 | Irinotecan | 02 | null | IRINOTECAN | 100127787 |
| 20222025 | 20180804 | 1.75 | 73.5 | Palliative (P) | 2019-10-08 | 2020-08-20 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | IRINOTECAN | 100851418 |
| 20222048 | 20180805 | 1.55 | 81.6 | Adjuvant (A) | 2019-12-06 | 2020-01-03 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | null | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101251843 |
| 20222603 | 20180806 | 1.59 | 53.45 | null | 2017-05-21 | 2017-05-21 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101233359 |
| 20222811 | 20180807 | 1.72 | null | Palliative (P) | 2017-03-02 | 2017-03-06 | Irinotecan | 02 | N | IRINOTECAN | 101581646 |
| 20222951 | 20180808 | 1.86 | 95 | Palliative (P) | 2020-02-27 | 2020-03-19 | FLUOROURACIL + IRINOTECAN | N | null | IRINOTECAN + MDG | 101348673 |
| 20223463 | 20180809 | 1.75 | 74.3 | null | 2017-07-29 | 2017-09-05 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 99 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100218749 |
| 20223741 | 20180810 | 1.72 | 73.4 | Adjuvant (A) | 2017-02-17 | 2017-02-17 | Irinotecan + Modified De Gramont | 02 | N | IRINOTECAN + MDG | 100284227 |
| 20223899 | 20180811 | 1.57 | 70.6 | null | 2019-08-03 | 2019-08-18 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101350599 |
| 20223978 | 20180812 | 1.6 | 65.3 | Palliative (P) | 2020-02-03 | 2020-02-10 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100936578 |
| 20224015 | 20180813 | 1.72 | 68.2 | Curative (C) | 2021-08-09 | 2021-08-29 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | Y | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100839151 |
| 20224037 | 20180814 | 1.53 | 96.4 | Palliative (P) | 2018-06-30 | 2018-08-02 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101596662 |
| 20224381 | 20180815 | 1.98 | 73.7 | null | 2016-06-25 | 2017-01-04 | GEMCITABINE + NAB PACLITAXEL | 02 | null | CAPECITABINE + CARBOPLATIN | 100311757 |
| 20224386 | 20180816 | 1.47 | 65.1 | Adjuvant (A) | 2019-06-28 | 2019-07-05 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100600064 |
| 20224653 | 20180817 | 1.8 | 62.2 | Palliative (P) | 2019-07-28 | 2019-08-04 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100633752 |
| 20224857 | 20180818 | 1.76 | 65.2 | Palliative (P) | 2018-10-03 | 2018-10-11 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 100499662 |
| 20224935 | 20180819 | 1.8 | 68 | Palliative (P) | 2016-08-11 | 2016-09-26 | HCX (Cape + Cisp + Tras) - Load | 02 | Y | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100659852 |
| 20224959 | 20180820 | 1.68 | 76.5 | Palliative (P) | 2018-03-22 | 2018-10-24 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101029100 |
| 20225173 | 20180821 | 1.87 | 77.9 | Adjuvant (A) | 2019-06-20 | 2019-09-28 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101728732 |
| 20001010 | 20180822 | 1.75 | 43 | null | 2017-11-19 | 2019-08-25 | ECX | null | null | ECX | 101744577 |
| 20004034 | 20180823 | 1.7 | 90 | Neo-adjuvant (N) | 2021-10-13 | 2021-10-14 | Panitumumab | null | null | PANITUMUMAB | 100599996 |
| 20004464 | 20180824 | 1.5 | 76 | Neo-adjuvant (N) | 2021-07-26 | 2021-11-26 | null | 02 | N | NIVOLUMAB | 101744780 |
| 20007469 | 20180825 | null | null | null | 2021-08-23 | 2021-09-03 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 100543302 |
| 20007934 | 20180826 | null | null | null | 2017-12-29 | 2018-01-02 | NIVOLUMAB | 2 | null | NIVOLUMAB | 100324232 |
| 20010911 | 20180827 | 1.9 | 77 | Adjuvant (A) | 2019-12-31 | 2020-01-22 | null | 02 | N | NIVOLUMAB | 101340964 |
| 20013573 | 20180829 | 1.65 | 65.6 | 03 | null | 2021-05-15 | null | N | N | ECX | 100579573 |
| 20018951 | 20180832 | 1.54 | 54.3 | null | 2019-10-07 | 2019-10-13 | Carboplatin + Etoposide iv&po | 02 | Y | CARBOPLATIN + ETOPOSIDE | 101044645 |
| 20022145 | 20180833 | 1.86 | 88.7 | Palliative (P) | 2020-12-29 | 2021-01-26 | null | 02 | N | ECX | 101355962 |
| 20027248 | 20180835 | 1.7 | null | null | 2022-04-12 | 2022-04-20 | ECX | 02 | null | ECX | 101162594 |
| 20028008 | 20180836 | 1.56 | null | null | null | 2020-08-07 | Cisplatin +Fluorouracil (3 wk) | null | N | CISPLATIN + FLUOROURACIL | 101441680 |
| 20028872 | 20180837 | 1.59 | 74.3 | Curative (C) | 2021-08-23 | 2021-09-05 | null | 02 | Y | CARBOPLATIN + ETOPOSIDE | 100200258 |
| 20029802 | 20180838 | null | 86 | null | 2019-04-22 | 2019-05-01 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 101807115 |
| 20031545 | 20180840 | 1.75 | 76 | Palliative (P) | 2018-03-31 | 2018-04-08 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100425276 |
| 20032098 | 20180841 | 1.82 | 106.6 | Palliative (P) | 2016-11-02 | 2016-11-02 | CAPECITABINE + RT | 02 | Y | CAPECITABINE + RT | 100651562 |
| 20032626 | 20180842 | 1.64 | 90 | Neo-adjuvant (N) | 2017-12-09 | 2017-12-23 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101198710 |
| 20032923 | 20180843 | 1.52 | 90.7 | null | 2021-02-14 | 2021-03-18 | GO2 TRIAL | 2 | N | TRIAL | 101446307 |
| 20033929 | 20180844 | 1.83 | 72.4 | Palliative (P) | 2018-02-12 | 2018-03-27 | Trial Unspecified | 02 | N | TRIAL | 100324324 |
| 20034946 | 20180845 | 1.79 | 89 | Neo-adjuvant (N) | 2017-09-06 | 2019-06-08 | Oxaliplatin + Raltitrexed | 02 | Y | OXALIPLATIN + RALTITREXED | 100762009 |
| 20036226 | 20180846 | 1.67 | 52 | Adjuvant (A) | 2017-02-03 | 2017-11-17 | EOX | 2 | null | SORAFENIB | 101801977 |
| 20038463 | 20180848 | 1.78 | 77 | null | 2018-01-21 | 2018-05-21 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100551030 |
| 20038481 | 20180849 | 1.59 | 75 | Palliative (P) | 2018-11-02 | 2018-11-02 | EOX | 02 | null | EOX | 100229133 |